Medicine and Dentistry
Head and Neck Cancer
100%
Radiation Therapy
60%
Neoplasm
55%
Biological Marker
54%
Oropharyngeal Cancer
54%
Positron Emission Tomography-Computed Tomography
36%
Xerostomia
36%
Radiomics
31%
Overall Survival
31%
Primary Tumor
29%
Chemoradiotherapy
28%
Bone Necrosis
27%
Magnetic Resonance Imaging
22%
Prognosis
22%
Lymph Node
21%
Computer Assisted Tomography
21%
Positron Emission Tomography
21%
Plummer-Vinson Syndrome
20%
Neck
20%
Risk Stratification
19%
Radiation Oncology
15%
Proton Therapy
14%
Parotid Gland
14%
Symptom
14%
Breast Cancer
13%
Distant Metastasis Free Survival
12%
Malignant Neoplasm
11%
Cancer Radiotherapy
11%
Oropharynx Squamous Cell Carcinoma
10%
Adaptive Radiotherapy
10%
Cross-Validation
9%
Proportional Hazards Model
9%
Recurrence Free Survival
9%
Clinician
9%
Dose-Volume Histogram
9%
Logistic Regression Analysis
9%
Nuclear Magnetic Resonance
8%
Robot-Assisted Surgery
8%
Prostate Cancer
8%
Esophageal Cancer
8%
Left Anterior Descending Coronary Artery
8%
Oropharynx Carcinoma
8%
Clinical Feature
8%
Side Effect
8%
Nasopharynx Cancer
7%
Survival Prediction
7%
Contouring
7%
Lower Jaw
7%
Disease
7%
Chemoradiation Therapy
6%
Keyphrases
Head-and-neck Cancer
23%
Cancer Patients
21%
Oropharyngeal Squamous Cell Carcinoma (OPSCC)
19%
PET Image
18%
Digital Biomarkers
17%
Radiotherapy
15%
18F-fluorodeoxyglucose Positron Emission Tomography (18F-FDG PET)
13%
Radiation Oncology
13%
Tumor
11%
Overall Survival
10%
Xerostomia
10%
Parotid Gland
9%
Prediction Model
9%
Late Xerostomia
9%
Cardiac Substructures
8%
Magnetic Resonance Imaging
8%
Cancer Segmentation
8%
Cancer Application
8%
Radiation-induced Xerostomia
8%
Probability Prediction Model
8%
Osteoradionecrosis
8%
Outcome Prediction
8%
Normal Tissue Complication Probability Models
7%
Dysphagia
6%
Radiation Pneumonitis
6%
Deep Learning Methods
5%
Tumor Segmentation
5%
Biomarker Model
5%
Primary Tumor
5%
Probability Map
5%
Deep Learning Model
5%
C-index
5%
Lymph Node
5%
Chemoradiotherapy
5%
CT Images
5%
Patient-specific
5%
Survival Outcomes
5%
Treatment Survival
5%